Jecho Biopharmaceuticals Co., Ltd.

This early-phase study tested a single injection of JL15003 in 17 adults whose glioblastoma brain cancer had come back after standard treatment. The main goal was to check safety and find the best dose, while also watching for signs of tumor shrinkage and how long patients lived.…

This study tested a new medicine called JL14002 against an existing drug (ranibizumab) for wet age-related macular degeneration, a condition that can cause rapid vision loss. The trial involved 443 adults aged 50 to 80 with active disease. The main goal was to see if JL14002 coul…